Background: Cardiogenic shock (CS) is associated with significant morbidity, and mortality rates approach 40% to 60%. Treatment for CS requires an aggressive, sophisticated, complex, goal‐oriented, therapeutic regimen focused on early revascularization and adjunctive supportive therapies, suggesting that hospitals with greater CS volume may provide better care. The association between CS hospital volume and inpatient mortality for CS is unclear. Methods and Results: We used the Nationwide Inpatient Sample to examine 533 179 weighted patient discharges from 2675 hospitals with CS from 2004 to 2011 and divided them into quartiles of mean annual hospital CS case volume. The primary outcome was in‐hospital mortality. Multivariate adjustments we...
BACKGROUND: Limited information is available on trends in the incidence of and mortality due to card...
Cardiogenic shock (CS) carries high mortality and morbidity. Early revascularization is an important...
Introduction: Cardiogenic shock (CS) mortality remains prohibitively high. A major limitation in the...
Background: Despite increasing use of mechanical circulatory support devices (MCS), cardiogenic shoc...
The mortality of cardiogenic shock (CS) remains unacceptably high. Delays in the recognition of CS a...
Aims To determine clinical correlates and optimal treatment strategy in patients with cardiogenic sh...
AbstractOBJECTIVESThis SHOCK Study report seeks to provide an overview of patients with cardiogenic ...
Background: There has been a rapid increase in the use of extracorporeal membrane oxygenation (ECMO)...
Abstract: Cardiogenic shock (CS) is the most common cause of death in hospitalized patients with acu...
Background Cardiogenic shock (CS) mortality remains prohibitively high. A major limitation has been ...
BACKGROUND: Risk stratifying patients with cardiogenic shock (CS) is a major unmet need. The recentl...
Conventional therapy for cardiogenic shock complicating acute myocardial infarction continues to be ...
Background There is increasing utilization of cardiogenic shock treatment algorithms. The cornerst...
Cardiogenic shock (CS) has a poor prognosis. The heterogeneity in the mortality through different su...
Acute myocardial infarction and cardiogenic shock (AMI-CS) is associated with significant morbidity ...
BACKGROUND: Limited information is available on trends in the incidence of and mortality due to card...
Cardiogenic shock (CS) carries high mortality and morbidity. Early revascularization is an important...
Introduction: Cardiogenic shock (CS) mortality remains prohibitively high. A major limitation in the...
Background: Despite increasing use of mechanical circulatory support devices (MCS), cardiogenic shoc...
The mortality of cardiogenic shock (CS) remains unacceptably high. Delays in the recognition of CS a...
Aims To determine clinical correlates and optimal treatment strategy in patients with cardiogenic sh...
AbstractOBJECTIVESThis SHOCK Study report seeks to provide an overview of patients with cardiogenic ...
Background: There has been a rapid increase in the use of extracorporeal membrane oxygenation (ECMO)...
Abstract: Cardiogenic shock (CS) is the most common cause of death in hospitalized patients with acu...
Background Cardiogenic shock (CS) mortality remains prohibitively high. A major limitation has been ...
BACKGROUND: Risk stratifying patients with cardiogenic shock (CS) is a major unmet need. The recentl...
Conventional therapy for cardiogenic shock complicating acute myocardial infarction continues to be ...
Background There is increasing utilization of cardiogenic shock treatment algorithms. The cornerst...
Cardiogenic shock (CS) has a poor prognosis. The heterogeneity in the mortality through different su...
Acute myocardial infarction and cardiogenic shock (AMI-CS) is associated with significant morbidity ...
BACKGROUND: Limited information is available on trends in the incidence of and mortality due to card...
Cardiogenic shock (CS) carries high mortality and morbidity. Early revascularization is an important...
Introduction: Cardiogenic shock (CS) mortality remains prohibitively high. A major limitation in the...